Pfiz­er's Hos­pi­ra is­sues a re­call for a batch of propo­fol due to a vis­i­ble par­tic­u­late

Pfiz­er’s Hos­pi­ra, plagued by qual­i­ty con­trol prob­lems at mul­ti­ple plants over the years, is once again find­ing it­self vol­un­tar­i­ly re­call­ing one lot of Propo­fol In­jectable …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER